CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of hypercortisolism in a population with difficult to control type 2 diabetes (T2D) (hemoglobin A1c ≥7.5%) despite receiving standard-of-car...
Phase 4
Cincinnati, Ohio, United States and 35 other locations
The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...
Phase 2
Cincinnati, Ohio, United States and 42 other locations
Multi-Center, Prospective, Randomized, Controlled Study to Evaluate the Safety and Efficacy of Topically Applied PEP-TISSEEL in Subjects with Diabetic...
Phase 2
Blue Ash, Ohio, United States
it takes the body to remove it in pediatric participants with Type 2 Diabetes Mellitus (T2DM). The study will last for approximately 100 day...
Phase 1
Cincinnati, Ohio, United States and 8 other locations
double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...
Phase 2
Cincinnati, Ohio, United States and 92 other locations
This is a randomized, masked, active-controlled, parallel-group, multi-center study that will assess the efficacy of ILUVIEN as a baseline therapy in...
Phase 4
Cincinnati, Ohio, United States and 39 other locations
This study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weigh...
Phase 2
Cincinnati, Ohio, United States and 90 other locations
The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...
Phase 3
Dayton, Ohio, United States and 48 other locations
in combination with a basal insulin (i.e., the Rapid-acting Insulin Analog \[RAA\] injection group) in pediatric subjects with type 1 or type 2 diabetes...
Phase 3
Cincinnati, Ohio, United States and 38 other locations
The main purpose of this study is to determine the safety and efficacy of orforglipron. Participants will have Type 2 Diabetes (T2D) and hav...
Phase 3
Cincinnati, Ohio, United States and 69 other locations
Clinical trials
Research sites
Resources
Legal